You are here

  • Home
  • Archive
  • Volume 76, Issue 1
  • Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hellgren K, Dreyer L, Arkema EV For the ARTIS Study Group, For the DANBIO Study Group, et al
Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
Annals of the Rheumatic Diseases 2017;76:105-111.